Higher mammography screening costs without appreciable clinical benefit: the case of digital mammography

J Natl Cancer Inst. 2014 Jul 16;106(8):dju191. doi: 10.1093/jnci/dju191. Print 2014 Aug.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / economics*
  • Breast Neoplasms / prevention & control
  • Direct Service Costs
  • Early Detection of Cancer / economics*
  • Early Detection of Cancer / methods*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Life Expectancy
  • Mammography / adverse effects
  • Mammography / economics*
  • Mammography / methods*
  • Mammography / standards
  • Mass Screening / adverse effects
  • Mass Screening / economics*
  • Mass Screening / methods*
  • Mass Screening / standards
  • Medicare
  • Middle Aged
  • Predictive Value of Tests
  • Radiographic Image Enhancement* / methods
  • Radiographic Image Enhancement* / trends
  • Risk Factors
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed*
  • United States